249 related articles for article (PubMed ID: 8095848)
1. Effect of L-buthionine sulfoximine on the radiation response of human renal carcinoma cell lines.
Leung SW; Mitchell JB; al-Nabulsi I; Friedman N; Newsome J; Belldegrun A; Kasid U
Cancer; 1993 Apr; 71(7):2276-85. PubMed ID: 8095848
[TBL] [Abstract][Full Text] [Related]
2. The toxic effects, GSH depletion and radiosensitivity by BSO on retinoblastoma.
Yi X; Ding L; Jin Y; Ni C; Wang W
Int J Radiat Oncol Biol Phys; 1994 May; 29(2):393-6. PubMed ID: 8195039
[TBL] [Abstract][Full Text] [Related]
3. Effects of glutathione depletion by buthionine sulfoximine on radiosensitization by oxygen and misonidazole in vitro.
Shrieve DC; Denekamp J; Minchinton AI
Radiat Res; 1985 Jun; 102(3):283-94. PubMed ID: 4070545
[TBL] [Abstract][Full Text] [Related]
4. Cellular glutathione depletion by diethyl maleate or buthionine sulfoximine: no effect of glutathione depletion on the oxygen enhancement ratio.
Mitchell JB; Russo A; Biaglow JE; McPherson S
Radiat Res; 1983 Nov; 96(2):422-8. PubMed ID: 6647769
[TBL] [Abstract][Full Text] [Related]
5. The radiation dose-response relationship in a human glioma xenograft and an evaluation of the influence of glutathione depletion by buthionine sulfoximine.
Halperin EC; Brizel DM; Honore G; Sontag MR; Griffith OW; Bigner DD; Friedman HS
Int J Radiat Oncol Biol Phys; 1992; 24(1):103-9. PubMed ID: 1512145
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of arsenic trioxide-induced apoptosis in renal cell carcinoma cells by L-buthionine sulfoximine.
Wu XX; Ogawa O; Kakehi Y
Int J Oncol; 2004 Jun; 24(6):1489-97. PubMed ID: 15138592
[TBL] [Abstract][Full Text] [Related]
7. Enhanced melphalan cytotoxicity in human ovarian cancer in vitro and in tumor-bearing nude mice by buthionine sulfoximine depletion of glutathione.
Ozols RF; Louie KG; Plowman J; Behrens BC; Fine RL; Dykes D; Hamilton TC
Biochem Pharmacol; 1987 Jan; 36(1):147-53. PubMed ID: 3801051
[TBL] [Abstract][Full Text] [Related]
8. Overcoming tumor necrosis factor-alpha resistance of human renal and ovarian carcinoma cells by combination treatment with buthionine sulfoximine and tumor necrosis factor-alpha. Role of tumor necrosis factor-alpha mRNA down-regulation in tumor cell sensitization.
Mizutani Y; Yoshida O
Cancer; 1994 Feb; 73(3):730-7. PubMed ID: 8299097
[TBL] [Abstract][Full Text] [Related]
9. Effects of glutathione depletion by buthionine sulfoximine on the sensitivity of EMT6/SF cells to chemotherapy agents or X radiation.
Shrieve DC; Harris JW
Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1171-4. PubMed ID: 3744936
[TBL] [Abstract][Full Text] [Related]
10. Depletion of intracellular GSH and NPSH by buthionine sulfoximine and diethyl maleate: factors that influence enhancement of aerobic radiation response.
Varnes ME; Biaglow JE; Roizin-Towle L; Hall EJ
Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1229-33. PubMed ID: 6469743
[TBL] [Abstract][Full Text] [Related]
11. Influence of intracellular glutathione concentration of lipofuscin accumulation in cultured neonatal rat cardiac myocytes.
Gao G; Ollinger K; Brunk UT
Free Radic Biol Med; 1994 Feb; 16(2):187-94. PubMed ID: 7911777
[TBL] [Abstract][Full Text] [Related]
12. Pharmacodynamics of prolonged treatment with L,S-buthionine sulfoximine.
Malaker K; Hurwitz SJ; Bump EA; Griffith OW; Lai LL; Riese N; Coleman CN
Int J Radiat Oncol Biol Phys; 1994 May; 29(2):407-12. PubMed ID: 7910818
[TBL] [Abstract][Full Text] [Related]
13. Glutathione depletion, radiosensitization, and misonidazole potentiation in hypoxic Chinese hamster ovary cells by buthionine sulfoximine.
Clark EP; Epp ER; Biaglow JE; Morse-Gaudio M; Zachgo E
Radiat Res; 1984 May; 98(2):370-80. PubMed ID: 6539482
[TBL] [Abstract][Full Text] [Related]
14. Factors involved in depletion of glutathione from A549 human lung carcinoma cells: implications for radiotherapy.
Biaglow JE; Varnes ME; Epp ER; Clark EP; Astor M
Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1221-7. PubMed ID: 6469742
[TBL] [Abstract][Full Text] [Related]
15. Toxic effects of acute glutathione depletion by buthionine sulfoximine and dimethylfumarate on murine mammary carcinoma cells.
Dethlefsen LA; Lehman CM; Biaglow JE; Peck VM
Radiat Res; 1988 May; 114(2):215-24. PubMed ID: 3375425
[TBL] [Abstract][Full Text] [Related]
16. Buthionine sulfoximine induction of gamma-L-glutamyl-L-cysteine synthetase gene expression, kinetics of glutathione depletion and resynthesis, and modulation of carmustine-induced DNA-DNA cross-linking and cytotoxicity in human glioma cells.
Ali-Osman F; Antoun G; Wang H; Rajagopal S; Gagucas E
Mol Pharmacol; 1996 Jun; 49(6):1012-20. PubMed ID: 8649339
[TBL] [Abstract][Full Text] [Related]
17. Sensitive enzymatic cycling assay for glutathione: measurements of glutathione content and its modulation by buthionine sulfoximine in vivo and in vitro in human colon cancer.
Berger SJ; Gosky D; Zborowska E; Willson JK; Berger NA
Cancer Res; 1994 Aug; 54(15):4077-83. PubMed ID: 8033140
[TBL] [Abstract][Full Text] [Related]
18. The effect of glutathione (GSH) depletion in vivo by buthionine sulfoximine (BSO) on the radiosensitization of SR 2508.
Kramer RA; Soble M; Howes AE; Montoya VP
Int J Radiat Oncol Biol Phys; 1989 May; 16(5):1325-9. PubMed ID: 2523885
[TBL] [Abstract][Full Text] [Related]
19. Glutathione depletion by L-buthionine sulfoximine antagonizes taxol cytotoxicity.
Liebmann JE; Hahn SM; Cook JA; Lipschultz C; Mitchell JB; Kaufman DC
Cancer Res; 1993 May; 53(9):2066-70. PubMed ID: 8097674
[TBL] [Abstract][Full Text] [Related]
20. Radiosensitization of mouse skin by oxygen and depletion of glutathione.
Stevens G; Joiner M; Joiner B; Johns H; Denekamp J
Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):399-408. PubMed ID: 7673027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]